Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study of Clinical Outcomes and Liver-related Toxicity of Patients With Lung Cancer Treated With Immune-checkpoint Inhibitors

NCT04595734 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.

NCT NCT04595734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study of Clinical Outcomes and Liver-related Toxicity of Patients With Lung Cancer Treated With Immune-checkpoint Inhibitors
Lead sponsor
Western Sydney Local Health District
Phase
Observational
Overall status
Unknown status
Start date
January 7, 2020
Completion date
January 6, 2025
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis, lung cancer stage iv, lung cancer, non-small cell